• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALYDIA HEALTH JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALYDIA HEALTH JADA SYSTEM; INTRAUTERINE VACUUM CONTRACTION SYSTEM Back to Search Results
Model Number JADA - 1001
Device Problem Obstruction of Flow (2423)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 04/02/2022
Event Type  malfunction  
Manufacturer Narrative
Based on the overall information currently provided in this report, there is a reasonable possibility that a potential malfunction (reported as "blood clotted in tubing - had to replace tubing.") has occurred with the jada system whereby if the suspected malfunction were to recur at a time when the patient was not under close observation, this malfunction could possibly cause or contribute to a death or serious injury.Out of an abundance of caution, the company will report this case as a malfunction mdr.Per the jada system ifu, "signs of patient deterioration or failure to improve indicate the need for reassessment and possibly more aggressive treatment and management of postpartum hemorrhage (pph)/abnormal postpartum uterine bleeding.", "evaluate for lacerations, retained products of conception, or other causes of bleeding prior to using jada." and "jada is not a substitute for surgical management and fluid resuscitation of life-threatening pph/abnormal postpartum uterine bleeding.".
 
Event Description
Alydia health received a completed jada experience survey form on 04/07/2022 that reported jada stopped the postpartum hemorrhage (pph) but noted "blood clotted in tubing - had to replace tubing." in the area on the survey designated for feedback when 'jada did not stop bleeding'.This patient in this case is described as multiparous with having obesity, hypertension, pre-eclampsia, and fibroids.She has a history of pph with previous deliveries.She had a vaginal induction and her pph started within one hour after delivery.Prior to jada use she received cytotec (600 units) and txa (1 g).The patient's blood loss prior to jada use reported as 1357 ml.The cervical seal was reported as filled with 120 ml of sterile fluid.Jada was reported to have controlled the pph bleeding in "greater than 10 minutes." additional information provided after a phone discussion, "mom did fine, she had a known fibroid 10 cm, on mag, previous pph, gushed, did the sweep 1-2 times before placement, no methergine due to hypertension, used txa, clotting in the tube, not a good suction, 80 mm hg increased to 90 mm then exchanged wall tubing, flushed and worked much better, by the time she placed jada there was 1000 ml blood loss , 300 ml in cannister, patient went to ob special care unit because she was on mag, txa may have changed the blood, very aggressive bleed, 5-10 minutes after placental delivery jada was placed, hemabate given after device placed." the lot number is not currently available for this event.Multiple requests were sent to this site for lot number and or device retention, no response to this request to date.A good faith effort to an obtain lot number has been attempted.This site only has the jada 1001 model currently.This report will be amended if we receive additional information regarding this event.Following the attempt to treat pph that uterotonics failed to treat, a jada device was inserted.The health care provider reported jada stopped the bleeding within ten minutes, there was 325 ml in the jada canister; and "blood clotted in tubing - had to replace tubing." we are reporting this as a mdr in an abundance of caution.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
JADA SYSTEM
Type of Device
INTRAUTERINE VACUUM CONTRACTION SYSTEM
Manufacturer (Section D)
ALYDIA HEALTH
3495 edison way
menlo park CA 94025
Manufacturer (Section G)
ALYDIA HEALTH
3495 edison way
menlo park CA 94025
Manufacturer Contact
heather wisler
3495 edison way
menlo park, CA 94025
8445232666
MDR Report Key14280042
MDR Text Key290768031
Report Number3017425145-2022-00081
Device Sequence Number1
Product Code OQY
UDI-Device Identifier00850017882003
UDI-Public(01)00850017882003
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K201199
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 05/03/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/04/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberJADA - 1001
Device Catalogue NumberJADA-1001
Was Device Available for Evaluation? No
Date Manufacturer Received04/07/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient SexFemale
-
-